Modulating autophagy in cancer therapy: Advancements and challenges for cancer cell death sensitization

Punya Bhat1, Jurgen Kriel2, Babu Shubha Priya1

  • 1DOS in Chemistry, University of Mysore, Manasgangotri, Mysuru 570006, Karnataka, India.

Biochemical Pharmacology
|December 6, 2017
PubMed

Insights

Autophagy, a cellular process, is crucial for cancer cell survival. Understanding its flux is key to developing new cancer therapies that overcome drug resistance.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Metabolism

Background:

  • Autophagy is a vital protein degradation pathway supporting cellular metabolism, especially in nutrient-poor conditions, benefiting rapidly growing tumor cells.
  • While autophagy's regulation is understood, its precise clinical application in cancer therapy is hindered by complexities.
  • The interplay between autophagic flux and tumor apoptosis susceptibility is not fully understood, complicating therapeutic strategies.

Purpose of the Study:

  • To clarify autophagy's role in tumor suppression by reviewing literature on autophagic flux and cellular metabolism.
  • To emphasize the need for accurate autophagic flux measurement techniques.
  • To explore the challenges in clinically targeting autophagy for cancer treatment.

Main Methods:

  • Literature review focusing on autophagic flux, cellular metabolism, and mitochondrial function in cancer.
  • Analysis of existing studies on the dynamic relationship between autophagy and apoptosis.
  • Discussion of clinical translatability and measurement techniques for autophagic flux.

Main Results:

  • Autophagic flux and its modulation have context-dependent effects on cancer cell death, with both increased flux and inhibition potentially sensitizing cells.
  • Accurate measurement of autophagic flux is a significant barrier to clinical translation.
  • The metabolic characteristics of cancer cells are critical for effective autophagy-targeted therapies.

Conclusions:

  • Accurate assessment of autophagic flux is essential for effective cancer therapy.
  • Targeting autophagy must consider the specific metabolic profile of cancer cells.
  • Overcoming tumor chemoresistance may be achieved through controlled autophagy modulation.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.7K